ResMed Inc. (RMD)
212.91
1.42 (0.67%)
At close: Apr 17, 2025, 3:59 PM
211.17
-0.82%
After-hours: Apr 17, 2025, 08:00 PM EDT
ResMed Revenue Breakdown
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sleep And Respiratory Revenue | 1.05B | 1.02B | 963.04M | 983.48M | 980.12M | 916.98M | 844.44M | 763.36M | 795.84M | 806.5M | 780.33M | 674.93M | 708.18M | 659.8M | 91.47M | 89.56M | 86.71M | 86.9M | 132.7M | 79.9M | 63.2M |
| Sleep And Respiratory Revenue Growth | +3.06% | +5.69% | -2.08% | +0.34% | +6.89% | +8.59% | +10.62% | -4.08% | -1.32% | +3.35% | +15.62% | -4.69% | +7.33% | +621.36% | +2.13% | +3.29% | -0.22% | -34.51% | +66.08% | +26.42% | n/a |
| Software As Service Revenue | 147.96M | 144.95M | 139.28M | 138.58M | 136.78M | 116.76M | 105.85M | 101.14M | 99.03M | 97.52M | 95.78M | n/a | n/a | 92.14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Software As Service Revenue Growth | +2.08% | +4.07% | +0.51% | +1.31% | +17.14% | +10.31% | +4.66% | +2.13% | +1.56% | +1.82% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | Jun 30, 2019 | Jun 30, 2018 | Jun 30, 2017 | Jun 30, 2016 | Jun 30, 2015 | Jun 30, 2014 | Jun 30, 2013 | Jun 30, 2012 | Jun 30, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Global Revenue | 1.5B | 3.58B | 3.2B | 2.96B | 2.61B | 994.98M | 684.26M | 408.18M | 344.29M | 315.6M | 293.36M | 263.12M | 237.21M |
| Global Revenue Growth | -57.99% | +11.93% | +8.11% | +13.44% | +161.97% | +45.41% | +67.64% | +18.56% | +9.09% | +7.58% | +11.50% | +10.92% | n/a |
| U [S] Revenue | 2.72B | n/a | n/a | n/a | n/a | 1.35B | 1.23B | n/a | n/a | n/a | n/a | 749.04M | 662.24M |
| U [S] Revenue Growth | n/a | n/a | n/a | n/a | n/a | +9.44% | n/a | n/a | n/a | n/a | n/a | +13.11% | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 241.61M | 238.98M | 242.19M | 229.92M | 222.16M | 222.87M | 240.69M | 228.46M | 211.67M | 193.93M | 194.89M | 182.4M | 185.36M | 176.72M | 181.48M | 160.45M | 169.47M | 158.99M | 165.38M | 172.44M | 171.42M | 167.44M | 171.6M | 164.53M | 161.58M | 147.3M | 156.81M | 147.89M | 151.82M | 143.85M | 147.94M | 137.86M | 139.31M | 128.85M | 133.93M | 119.35M | 118.22M | 111.09M | 123.25M | 116.34M |
| Selling, General, and Administrative Revenue Growth | +1.10% | -1.32% | +5.34% | +3.49% | -0.32% | -7.40% | +5.35% | +7.93% | +9.15% | -0.49% | +6.85% | -1.60% | +4.89% | -2.63% | +13.11% | -5.32% | +6.59% | -3.87% | -4.09% | +0.59% | +2.38% | -2.42% | +4.30% | +1.83% | +9.69% | -6.06% | +6.03% | -2.58% | +5.54% | -2.77% | +7.31% | -1.04% | +8.11% | -3.79% | +12.21% | +0.96% | +6.41% | -9.86% | +5.94% | n/a |
| Research and Development Revenue | 81.37M | 79.52M | 80.86M | 77.07M | 73.88M | 75.71M | 78.14M | 76.44M | 69.87M | 63.19M | 64.32M | 66.8M | 62.51M | 59.95M | 59.88M | 55.94M | 54.94M | 54.53M | 52.52M | 51.45M | 49.94M | 48.03M | 51.14M | 47.61M | 43.11M | 38.79M | 39.66M | 37.43M | 40.64M | 37.41M | 36.71M | 35.13M | 38.19M | 34.45M | 34.38M | 28.11M | 28.97M | 27.19M | 28.52M | 27.02M |
| Research and Development Revenue Growth | +2.33% | -1.65% | +4.91% | +4.32% | -2.42% | -3.11% | +2.23% | +9.39% | +10.58% | -1.76% | -3.72% | +6.87% | +4.27% | +0.13% | +7.03% | +1.83% | +0.74% | +3.83% | +2.08% | +3.02% | +3.98% | -6.07% | +7.41% | +10.44% | +11.14% | -2.18% | +5.94% | -7.90% | +8.63% | +1.93% | +4.49% | -8.01% | +10.87% | +0.19% | +22.31% | -2.97% | +6.54% | -4.67% | +5.55% | n/a |